Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth H Mayer

Showing results (961-970 of 997) with videos related to

Pageof 100
Sort By:
HIV Clinical Trials|April 8, 2017
Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIVMarisela Noorhasan, Daniel R Drozd, Carl Grunfeld, et al.
Plos One|July 28, 2017
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender womenAlex Carballo-Diéguez, Ivan C Balán, William Brown, et al.
AIDS (London, England)|July 7, 2022
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United StatesRachel A Bender Ignacio, Adrienne E Shapiro, Robin M Nance, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)Stephen Walsh, William O Hahn, Wilton B Williams, et al.
Drug and Alcohol Dependence|October 10, 2022
Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatmentHeidi M Crane, Stephanie A Ruderman, Bridget M Whitney, et al.
Analytical Chemistry|May 20, 2008
Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter studyRaina N Fichorova, Nicola Richardson-Harman, Massimo Alfano, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 27, 2023
Evaluating the Sick Quitting Hypothesis for Frailty Status and Reducing Alcohol Use Among People With HIV in a Longitudinal Clinical Cohort StudyStephanie A Ruderman, Lydia N Drumright, Joseph A C Delaney, et al.
Plos Pathogens|May 11, 2016
Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusDamien C Tully, Colin B Ogilvie, Rebecca E Batorsky, et al.
AIDS (London, England)|February 1, 2023
Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIVStephanie A Ruderman, Robin M Nance, Lydia N Drumright, et al.
Pageof 100

Showing results (961-970 of 997) with videos related to

Sort By:
Pageof 100
HIV Clinical Trials|April 8, 2017
Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H Eshleman, Ethan A Wilson, Xinyi C Zhang, et al.
AIDS Research and Human Retroviruses|January 17, 2017
Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIVMarisela Noorhasan, Daniel R Drozd, Carl Grunfeld, et al.
Plos One|July 28, 2017
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender womenAlex Carballo-Diéguez, Ivan C Balán, William Brown, et al.
AIDS (London, England)|July 7, 2022
Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United StatesRachel A Bender Ignacio, Adrienne E Shapiro, Robin M Nance, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Safety and immunogenicity of an HIV envelope trimer immunogen that elicits CD4 binding site neutralizing antibody precursors (HVTN 300)Stephen Walsh, William O Hahn, Wilton B Williams, et al.
Drug and Alcohol Dependence|October 10, 2022
Associations between drug and alcohol use, smoking, and frailty among people with HIV across the United States in the current era of antiretroviral treatmentHeidi M Crane, Stephanie A Ruderman, Bridget M Whitney, et al.
Analytical Chemistry|May 20, 2008
Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter studyRaina N Fichorova, Nicola Richardson-Harman, Massimo Alfano, et al.
The Journal of the Association of Nurses in AIDS Care : JANAC|December 27, 2023
Evaluating the Sick Quitting Hypothesis for Frailty Status and Reducing Alcohol Use Among People With HIV in a Longitudinal Clinical Cohort StudyStephanie A Ruderman, Lydia N Drumright, Joseph A C Delaney, et al.
Plos Pathogens|May 11, 2016
Differences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusDamien C Tully, Colin B Ogilvie, Rebecca E Batorsky, et al.
AIDS (London, England)|February 1, 2023
Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIVStephanie A Ruderman, Robin M Nance, Lydia N Drumright, et al.
Pageof 100